US-based Prometrika and Comprehend Systems have announced a partnership to address the changing needs of biotech and pharmaceutical sponsors that run clinical trials.
Prometrika noted that many of its clients were requesting improved data analytics and reporting capabilities.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Sponsors are moving away from traditional data reporting toward the ability to compare data from multiple studies within a programme. The traditional reporting was exclusive to a single study,
Prometrika president and CEO Miganush Stepanians said: “Comprehend aligns with our mission of helping sponsors achieve successful clinical development through advances in data science.
“After an extensive review process, we selected Comprehend’s Clinical Intelligence Suite for its clinical-focused functionality, ease of deployment, and overall cost effectiveness. The solution is the best fit for our business and meets the evolving needs of our clients.”
Comprehend’s solutions are used by Prometrika to collect data from multiple sources such as EDC, Labs, CTMS, ePRO, IxRS, and eTMF, and update the sourced data in real time and deliver on-demand dynamic line listings and graphical patient profiles within and across studies.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataStepanians further added: “Our clients are now able to securely explore their own data, with visibility into multiple data sets in a single view, and run descriptive analytics customized for their medical data review and centralized monitoring strategies.”
Industry surveys reveal global desire for data unification, improved visibility, and cross-study comparisons, yet very few sponsors use data with any regularity.
Comprehend founder and president Rick Morrison said that CROs such as Prometrika can gain advantage by steering sponsors toward solutions that make clinical research effective.
